What is the differential diagnosis for a patient with colonic strictures, pyloric antral strictures, and imaging/endoscopy findings suggestive of Inflammatory Bowel Disease (IBD), bulky ovaries, ascites, myositis of the bilateral iliopsoas and lateral compartment of the leg, and a positive Cancer Antigen (CA) 19.9?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis

This patient presents with a complex multisystem inflammatory syndrome that extends well beyond typical IBD, requiring immediate consideration of IgG4-related disease, malignancy (particularly ovarian with peritoneal carcinomatosis), tuberculosis despite negative QuantiFERON, and systemic vasculitis as primary diagnostic considerations.

Primary Diagnostic Considerations

IgG4-Related Disease

  • IgG4-related disease is the leading diagnosis given the constellation of gastrointestinal strictures (both colonic and gastric), myositis, and ovarian involvement with ascites 1
  • This condition characteristically causes tumefactive lesions and strictures in multiple organs simultaneously, including the GI tract, retroperitoneum (explaining iliopsoas myositis), and can involve ovaries 1
  • Elevated CA 19-9 is frequently seen in IgG4-related disease affecting the pancreaticobiliary system and can occur with other organ involvement 1
  • Diagnosis requires serum IgG4 levels >135 mg/dL and tissue biopsy showing >10 IgG4-positive plasma cells per high-power field with IgG4/IgG ratio >40% 1

Ovarian Malignancy with Peritoneal Carcinomatosis

  • Bulky ovaries with ascites and elevated CA 19-9 strongly suggest ovarian cancer with peritoneal spread 2
  • Peritoneal carcinomatosis can cause colonic strictures through serosal involvement and mimic IBD endoscopically 1
  • Gastric involvement (pyloric antral strictures) occurs with peritoneal metastases, particularly from ovarian primary tumors 2
  • Urgent gynecologic oncology consultation with CA-125, pelvic MRI, and diagnostic paracentesis with cytology is mandatory 2

Intestinal Tuberculosis

  • Despite negative QuantiFERON, intestinal TB remains in the differential given the stricturing disease pattern 3
  • QuantiFERON has 70-80% sensitivity; false negatives occur with immunosuppression, disseminated disease, and in 20-30% of culture-proven TB cases 3
  • Ileocecal involvement with strictures, patulous ileocecal valve, and transverse ulcers favor TB over Crohn's disease 3
  • Obtain AFB cultures from endoscopic biopsies, PCR for Mycobacterium tuberculosis from tissue, and consider empiric anti-TB therapy if clinical suspicion remains high 3, 1

Systemic Vasculitis

  • Myositis (bilateral iliopsoas and leg compartments) combined with GI involvement suggests medium-vessel vasculitis such as polyarteritis nodosa 1, 4
  • Mesenteric vasculitis causes intestinal ischemia leading to strictures that can mimic IBD 1
  • Check ANCA panel, complement levels (C3, C4), cryoglobulins, and hepatitis B/C serology 4
  • Muscle biopsy from affected areas may show vasculitic changes 4

Secondary Considerations

Crohn's Disease with Extraintestinal Manifestations

  • While endoscopy suggests IBD, the extensive extraintestinal involvement (myositis, ovarian masses) is atypical for standard Crohn's disease 5, 6
  • Crohn's can cause discontinuous lesions and strictures, but bilateral iliopsosis myositis is not a recognized extraintestinal manifestation 5, 4
  • Ovarian involvement is exceptionally rare in IBD and should prompt investigation for alternative diagnoses 6, 4

Lymphoma

  • IBD patients have increased lymphoma risk, particularly with immunosuppressive therapy 2
  • Gastrointestinal lymphoma can cause strictures, bulky masses (explaining ovarian appearance), and systemic symptoms 2
  • Elevated CA 19-9 can occur with lymphoma 2
  • PET-CT scan is essential to evaluate for lymphoproliferative disease 2

Critical Diagnostic Workup

Immediate Laboratory Studies

  • Serum IgG4 level (most important single test given clinical presentation) 1
  • CA-125, CEA, AFP in addition to CA 19-9 2
  • Complete autoimmune panel: ANA, ANCA (PR3 and MPO), anti-dsDNA, complement levels 4
  • Repeat inflammatory markers: ESR, CRP, complete blood count with differential 3
  • Serum protein electrophoresis to exclude paraproteinemia 4

Tissue Diagnosis Required

  • Repeat endoscopic biopsies with specific request for IgG4 immunostaining, AFB cultures, TB PCR, and lymphoma markers (CD20, CD3, CD5) 3
  • Muscle biopsy from affected iliopsoas or leg compartment for histology, vasculitis assessment, and cultures 4
  • Image-guided biopsy of ovarian mass if accessible 2
  • Diagnostic paracentesis with cytology, cell count, albumin, LDH, and cultures 2

Advanced Imaging

  • PET-CT to assess metabolic activity in all affected sites and identify occult malignancy or lymphoma 2
  • Contrast-enhanced MRI of abdomen/pelvis already obtained; review for characteristic IgG4 findings (sausage-shaped pancreas, retroperitoneal fibrosis) 1
  • Consider whole-body MRI if systemic vasculitis suspected 4

Critical Pitfalls to Avoid

  • Do not assume this is straightforward IBD despite endoscopic appearance suggesting inflammatory bowel disease; the multisystem involvement demands broader investigation 3, 1
  • Do not dismiss TB based solely on negative QuantiFERON; obtain tissue for AFB culture and TB PCR, which have higher sensitivity in GI tuberculosis 3, 1
  • Do not delay gynecologic oncology evaluation given the combination of bulky ovaries, ascites, and elevated tumor marker 2
  • Do not start immunosuppressive therapy until malignancy and infection are definitively excluded, as this could be catastrophic 1, 2
  • Recognize that CA 19-9 elevation is non-specific and occurs in IgG4 disease, malignancy, and inflammatory conditions 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.